Curated News
By: NewsRamp Editorial Staff
September 23, 2025
NuggMD Expands to Germany: First US Cannabis Telehealth Platform Goes Global
TLDR
- NuggMD's expansion into Germany gives the company first-mover advantage as the first U.S. cannabis telehealth platform to operate internationally, positioning it for European market dominance.
- NuggMD's platform connects patients with doctors via telehealth, using Germany's centralized medical cannabis system where approved patients can purchase cannabis immediately after evaluation.
- NuggMD's expansion improves global access to medical cannabis, allowing more patients to make informed wellness decisions under doctor guidance for better healthcare outcomes.
- NuggMD becomes the first U.S. cannabis telehealth company to expand internationally, bringing its decade of experience to Germany's rapidly growing medical cannabis market.
Impact - Why it Matters
This expansion matters because it represents a significant advancement in global medical cannabis accessibility, potentially setting a precedent for other countries considering similar telehealth models. For patients in Germany, it means faster, more convenient access to medical cannabis evaluations from an experienced provider with a proven track record. The move demonstrates how successful American cannabis companies can translate their expertise to international markets, potentially accelerating the global normalization of medical cannabis. As more countries liberalize their cannabis laws, having established, reputable platforms like NuggMD enter new markets helps ensure patient safety, quality standards, and reliable access. This development could pressure other nations to modernize their medical cannabis systems, ultimately benefiting patients worldwide who seek alternative treatment options under proper medical supervision.
Summary
NuggMD, the pioneering California-based medical cannabis telehealth platform, has made history by expanding into Germany, marking the first time a U.S.-based cannabis telehealth service has crossed international borders. The company, which has built a formidable 10-year track record serving patients in 31 state-legal U.S. markets, is now serving patients in Germany through its new platform at nuggmd.de. This strategic move represents a significant milestone for the medical cannabis industry, demonstrating how American expertise in navigating complex regulatory environments can translate to international markets. CEO Charlie Russell emphasized that their extensive experience operating successfully in the contradictory U.S. landscape, where cannabis remains federally illegal but state-legal, has provided the institutional knowledge necessary to thrive in Germany's more centralized system.
The expansion comes at a pivotal moment for Germany's medical cannabis landscape, which has implemented a patient-centric regulatory approach that data suggests is working effectively. According to a recent survey of more than 11,000 German cannabis consumers, nearly 90% obtain their cannabis from legal sources, indicating strong adoption of the regulated market. This centralized system allows patients to purchase cannabis immediately after receiving a positive medical determination, creating a significantly better patient experience compared to more fragmented approaches. The German model's success provides an encouraging environment for NuggMD's international debut, with the company noting that European cannabis markets are poised for rapid growth due to appropriate policy frameworks that prioritize patient access and safety.
NuggMD's German expansion represents more than just business growth—it signifies a major step forward in global medical cannabis accessibility. Since its founding in 2015, the platform has connected over 2 million patients with medical marijuana doctors through its state-of-the-art telehealth services. The company's mission centers on helping people achieve fast, reliable access to plant-based medicine where it's legal, empowering individuals to make informed decisions about their wellness options under medical guidance. This international move demonstrates the growing normalization and acceptance of medical cannabis worldwide, with NuggMD positioning itself as a leader in the global movement toward accessible, doctor-supervised cannabis treatment options that prioritize patient care and safety above all else.
Source Statement
This curated news summary relied on content disributed by Newsworthy.ai. Read the original source here, NuggMD Expands to Germany: First US Cannabis Telehealth Platform Goes Global
